BTSG BrightSpring Health Services (BTSG) Q1 FY26 earnings call
BrightSpring delivered strong Q1 FY26 results, driven by broad-based growth in both pharmacy and provider segments and significant margin expansion. The company successfully integrated recent home health acquisitions and reduced leverage post-divestiture, positioning it for continued strategic investments and operational efficiencies despite expected IRA headwinds in Home & Community Pharmacy.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
BTSG operating KPIs by quarter
| KPI | This call Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|
| LDDs | 153We continue to see strong volume performance from both brand LDDs and generics, and we added 4 exclusive and UltraAR LDDs to our portfolio in the first quarter, bringing our total number of LDDs to 153.Source: earnings call transcript | 155During the quarter, we added 2 ultra-narrow network LDDs to our portfolio bringing the total number of LDDs to 155.Source: earnings call transcript | +1.3% |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.